Literature DB >> 27793746

Evaluation of the Tobacco Heating System 2.2. Part 4: 90-day OECD 413 rat inhalation study with systems toxicology endpoints demonstrates reduced exposure effects compared with cigarette smoke.

Ee Tsin Wong1, Ulrike Kogel2, Emilija Veljkovic1, Florian Martin2, Yang Xiang2, Stephanie Boue2, Gregory Vuillaume2, Patrice Leroy2, Emmanuel Guedj2, Gregory Rodrigo3, Nikolai V Ivanov2, Julia Hoeng2, Manuel C Peitsch2, Patrick Vanscheeuwijck4.   

Abstract

The objective of the study was to characterize the toxicity from sub-chronic inhalation of test atmospheres from the candidate modified risk tobacco product (MRTP), Tobacco Heating System version 2.2 (THS2.2), and to compare it with that of the 3R4F reference cigarette. A 90-day nose-only inhalation study on Sprague-Dawley rats was performed, combining classical and systems toxicology approaches. Reduction in respiratory minute volume, degree of lung inflammation, and histopathological findings in the respiratory tract organs were significantly less pronounced in THS2.2-exposed groups compared with 3R4F-exposed groups. Transcriptomics data obtained from nasal epithelium and lung parenchyma showed concentration-dependent differential gene expression following 3R4F exposure that was less pronounced in the THS2.2-exposed groups. Molecular network analysis showed that inflammatory processes were the most affected by 3R4F, while the extent of THS2.2 impact was much lower. Most other toxicological endpoints evaluated did not show exposure-related effects. Where findings were observed, the effects were similar in 3R4F- and THS2.2-exposed animals. In summary, toxicological changes observed in the respiratory tract organs of THS2.2 aerosol-exposed rats were much less pronounced than in 3R4F-exposed rats while other toxicological endpoints either showed no exposure-related effects or were comparable to what was observed in the 3R4F-exposed rats.
Copyright © 2016 The Author(s). Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Heat-not-burn; Inhalation systems toxicology; Inhalation toxicology study; Modified risk tobacco product; Pulmonary inflammation

Mesh:

Substances:

Year:  2016        PMID: 27793746     DOI: 10.1016/j.yrtph.2016.10.015

Source DB:  PubMed          Journal:  Regul Toxicol Pharmacol        ISSN: 0273-2300            Impact factor:   3.271


  17 in total

Review 1.  Modeling drug exposure in rodents using e-cigarettes and other electronic nicotine delivery systems.

Authors:  Cristina Miliano; E Reilly Scott; Laura B Murdaugh; Emma R Gnatowski; Christine L Faunce; Megan S Anderson; Malissa M Reyes; Ann M Gregus; Matthew W Buczynski
Journal:  J Neurosci Methods       Date:  2019-10-12       Impact factor: 2.390

Review 2.  Should IQOS Emissions Be Considered as Smoke and Harmful to Health? A Review of the Chemical Evidence.

Authors:  Clement N Uguna; Colin E Snape
Journal:  ACS Omega       Date:  2022-06-22

3.  Toxicity evaluation in rats following 28 days of inhalation exposure to xylitol aerosol.

Authors:  Yushan Tian; Hongjuan Wang; Huan Chen; Xianmei Li; Fengjun Lu; Shuhao Ma; Wenming Wang; Jia Wu; Jiayou Tang; Pengxia Feng; Yaning Fu; Shulei Han; Tong Liu; Hongwei Hou; Qingyuan Hu
Journal:  Toxicol Res (Camb)       Date:  2021-11-26       Impact factor: 3.524

4.  Evaluation of toxicity of aerosols from flavored e-liquids in Sprague-Dawley rats in a 90-day OECD inhalation study, complemented by transcriptomics analysis.

Authors:  Jenny Ho; Davide Sciuscio; Ulrike Kogel; Bjoern Titz; Patrice Leroy; Gregory Vuillaume; Marja Talikka; Elyette Martin; Pavel Pospisil; Stefan Lebrun; Wenhao Xia; Tom Lee; Yun Xuan Chng; Blaine W Phillips; Emilija Veljkovic; Emmanuel Guedj; Yang Xiang; Nikolai V Ivanov; Manuel C Peitsch; Julia Hoeng; Patrick Vanscheeuwijck
Journal:  Arch Toxicol       Date:  2020-05-05       Impact factor: 5.153

5.  Possible hepatotoxicity of IQOS.

Authors:  Lauren Chun; Farzad Moazed; Michael Matthay; Carolyn Calfee; Jeffrey Gotts
Journal:  Tob Control       Date:  2018-08-21       Impact factor: 7.552

6.  Assessment of industry data on pulmonary and immunosuppressive effects of IQOS.

Authors:  Farzad Moazed; Lauren Chun; Michael A Matthay; Carolyn S Calfee; Jeffrey Gotts
Journal:  Tob Control       Date:  2018-08-29       Impact factor: 7.552

7.  Potential predictors of adoption of the Tobacco Heating System by U.S. adult smokers: An actual use study.

Authors:  Steve Roulet; Christelle Chrea; Claudia Kanitscheider; Gerd Kallischnigg; Pierpaolo Magnani; Rolf Weitkunat
Journal:  F1000Res       Date:  2019-02-24

Review 8.  Exposure to Heated Tobacco Products and Adverse Health Effects, a Systematic Review.

Authors:  Małgorzata Znyk; Joanna Jurewicz; Dorota Kaleta
Journal:  Int J Environ Res Public Health       Date:  2021-06-21       Impact factor: 3.390

9.  Cytotoxic effects of heated tobacco products (HTP) on human bronchial epithelial cells.

Authors:  Noel J Leigh; Phillip L Tran; Richard J O'Connor; Maciej Lukasz Goniewicz
Journal:  Tob Control       Date:  2018-09-05       Impact factor: 7.552

10.  Vascular endothelial function is impaired by aerosol from a single IQOS HeatStick to the same extent as by cigarette smoke.

Authors:  Pooneh Nabavizadeh; Jiangtao Liu; Christopher M Havel; Sharina Ibrahim; Ronak Derakhshandeh; Peyton Jacob Iii; Matthew L Springer
Journal:  Tob Control       Date:  2018-09-11       Impact factor: 7.552

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.